Peptide questions · Dulaglutide
How long does dulaglutide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Dulaglutide’s onset is days–2 weeks, its peak effect comes at 24–52 weeks (glucose), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: FDA Trulicity label (DailyMed, effective June 2026); AWARD-11 (Frias 2021); REWIND (Gerstein 2019); SUSTAIN 7 (Pratley 2018). Approved for type 2 diabetes, not weight management.
Dulaglutide week by week
The library places five of its research notes on dulaglutide on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | The 0.75 mg start | Randomized trial |
| Days 29–364 (weeks 5–52) | 1.5 mg, the dose of its heart trial | Randomized trial |
| Days 57–364 (weeks 9–52) | 3 mg, a step for more glucose control | Randomized trial |
| Days 85–364 (weeks 13–52) | 4.5 mg, the top dose | Randomized trial |
| From day 365 on | A long-term medicine, not a course | Randomized trial |

Model. Individual results vary.
The dulaglutide timeline’s milestones
The library’s timeline for dulaglutide marks 7 points from week 1 to week 40, backed by clinical trial data overall.
- Week 1: Commonly reported: a little nausea or a smaller appetite in the days after the first shot
- Week 2: Drug levels build toward a steady state over the first 2 to 4 weekly doses (label)
- Week 4: The label's first optional step, from 0.75 to 1.5 mg, for more glucose control
- Week 8: Commonly reported: steadier glucose readings, with GI side effects calmer than in the first month
- Week 12: From 1.5 mg, the label allows 1.5 mg steps after 4 weeks or more on a dose, up to 4.5 mg
- Week 26: Its trials read the glucose change as HbA1c, the long-run glucose marker, at 24 to 52 weeks
- Week 40: In its head-to-head trial, semaglutide lowered weight and glucose more than dulaglutide did
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why dulaglutide takes that long
Dulaglutide’s half-life is about 5 days (120 hours), so one dose is about 96.9% cleared after 25 days.
On its schedule (Weekly) the doses overlap, and the level of dulaglutide keeps climbing for about 20–25 days before it levels off, so the first 20–25 days run below the level the later weeks hold.
The notes on dulaglutide follow the trials’ dose steps, 0.75mg, 1.5mg, 3mg and 4.5mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Dulaglutide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, dulaglutide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does dulaglutide take to work?
Dulaglutide’s onset is days–2 weeks, its peak effect comes at 24–52 weeks (glucose), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does dulaglutide reach its peak effect?
By the library’s timeline, dulaglutide’s peak effect comes at 24–52 weeks (glucose), backed by clinical trial data.
How long is dulaglutide usually run?
The library’s timeline gives dulaglutide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use; its heart-outcomes trial followed people for a median of 5.4 years.
What does the library say about the first days on dulaglutide?
Its first note on dulaglutide, for days 1–28 (weeks 1–4), is “The 0.75 mg start”, resting on randomized trials.